Your browser doesn't support javascript.
loading
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis.
Nazarzadeh, Milad; Bidel, Zeinab; Canoy, Dexter; Copland, Emma; Wamil, Malgorzata; Majert, Jeannette; Smith Byrne, Karl; Sundström, Johan; Teo, Koon; Davis, Barry R; Chalmers, John; Pepine, Carl J; Dehghan, Abbas; Bennett, Derrick A; Smith, George Davey; Rahimi, Kazem.
Afiliação
  • Nazarzadeh M; Deep Medicine, Oxford Martin School, University of Oxford, Oxford, UK; Nuffield Department of Women's and Reproductive Health, Medical Science Division, University of Oxford, Oxford, UK.
  • Bidel Z; Deep Medicine, Oxford Martin School, University of Oxford, Oxford, UK; Nuffield Department of Women's and Reproductive Health, Medical Science Division, University of Oxford, Oxford, UK.
  • Canoy D; Deep Medicine, Oxford Martin School, University of Oxford, Oxford, UK; Nuffield Department of Women's and Reproductive Health, Medical Science Division, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Copland E; Deep Medicine, Oxford Martin School, University of Oxford, Oxford, UK; Nuffield Department of Women's and Reproductive Health, Medical Science Division, University of Oxford, Oxford, UK.
  • Wamil M; Deep Medicine, Oxford Martin School, University of Oxford, Oxford, UK.
  • Majert J; Deep Medicine, Oxford Martin School, University of Oxford, Oxford, UK; Nuffield Department of Women's and Reproductive Health, Medical Science Division, University of Oxford, Oxford, UK.
  • Smith Byrne K; International Agency for Research on Cancer/WHO, Genomic Epidemiology Branch, Lyon, France.
  • Sundström J; Clinical Epidemiology Unit, Department of Medical Sciences, Uppsala University, Uppsala, Sweden; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
  • Teo K; Population Health Research Institute, McMaster University, Hamilton, ON, Canada.
  • Davis BR; The University of Texas School of Public Health, Houston, TX, USA.
  • Chalmers J; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
  • Pepine CJ; Department of Medicine, University of Florida, Gainesville, FL, USA.
  • Dehghan A; Department of Biostatistics and Epidemiology, School of Public Health, Imperial College London, London, UK.
  • Bennett DA; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Smith GD; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
  • Rahimi K; Deep Medicine, Oxford Martin School, University of Oxford, Oxford, UK; Nuffield Department of Women's and Reproductive Health, Medical Science Division, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic
Lancet ; 398(10313): 1803-1810, 2021 11 13.
Article em En | MEDLINE | ID: mdl-34774144

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hipertensão / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hipertensão / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido